- Home
- OPAD vs YI Comparison
OPAD vs YI Comparison
Compare OPAD & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- YI
- Stock Information
- Founded
- OPAD 2015
- YI 2010
- Country
- OPAD United States
- YI China
- Employees
- OPAD N/A
- YI N/A
- Industry
- OPAD Real Estate
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- OPAD Finance
- YI Consumer Staples
- Exchange
- OPAD Nasdaq
- YI Nasdaq
- Market Cap
- OPAD 70.1M
- YI 74.0M
- IPO Year
- OPAD N/A
- YI N/A
- Fundamental
- Price
- OPAD $1.71
- YI $8.10
- Analyst Decision
- OPAD Hold
- YI
- Analyst Count
- OPAD 5
- YI 0
- Target Price
- OPAD $3.25
- YI N/A
- AVG Volume (30 Days)
- OPAD 85.3K
- YI 32.8K
- Earning Date
- OPAD 05-05-2025
- YI 03-20-2025
- Dividend Yield
- OPAD N/A
- YI N/A
- EPS Growth
- OPAD N/A
- YI N/A
- EPS
- OPAD N/A
- YI N/A
- Revenue
- OPAD $918,819,000.00
- YI $2,090,255,896.00
- Revenue This Year
- OPAD $8.29
- YI $61.85
- Revenue Next Year
- OPAD $33.17
- YI N/A
- P/E Ratio
- OPAD N/A
- YI N/A
- Revenue Growth
- OPAD N/A
- YI N/A
- 52 Week Low
- OPAD $1.64
- YI $0.41
- 52 Week High
- OPAD $8.79
- YI $9.16
- Technical
- Relative Strength Index (RSI)
- OPAD 34.34
- YI 62.94
- Support Level
- OPAD $1.64
- YI $7.00
- Resistance Level
- OPAD $2.09
- YI $9.16
- Average True Range (ATR)
- OPAD 0.20
- YI 0.55
- MACD
- OPAD -0.01
- YI -0.26
- Stochastic Oscillator
- OPAD 8.28
- YI 50.93
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.